The Chemours (CC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CC quarterly Cash Flow →
A period-by-period view of cash flow from The Chemours to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-386.00
Depreciation & amortization340.00
Amortization of Other Assets11.00
Write-down of investments0.00
Restructuring Costs and Asset Impairment Charges32.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories and Other Operating Assets-106.00
Share-based plans0.00
Gain (Loss) on Disposition of Assets, Total-8.00
Share-based Compensation-2.00
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions-7.00
Gains (Losses) on Extinguishment of Debt5.00
Defined Benefit Plan Contributions-2.00
Income taxes64.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts and Notes Receivable106.00
Increase (Decrease) in Accounts Payable-165.00
Accrued expenses0.00
Other receivables0.00
Financing valuation provision0.00
Other Working Capital343.00
Prepaid expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities39.00
Discontinued operations0.00
Net Cash flow from Operating Activities264.00
Investing Activities
Capital Expenditures-213.00
Sale of Capital Items7.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Payments for (Proceeds from) Derivative Instrument, Investing Activities-1.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Repayments of Accounts Receivable Securitization0.00
Proceeds from Life Insurance Policies1.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-206.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-7.00
Long-term debt - borrowings748.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.00
Proceeds from Contributions from Parent0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net12.00
Proceeds from Payments of Contributionsto Parent-
Proceeds From Payments Of Contributions To Parent-
Proceeds From Issuance Of Long Term Debt Excluding Lines Of Credit-
Repayments Of Long Term Debt Excluding Lines Of Credit-787.00
Finance Lease Principal Payments-14.00
Deferred Acquisition Related Considerations-
Proceeds From Supplier Financing Programs-
Payments To Supplier Financing Programs-
Dividends paid to minority interests0.00
Dividends paid-78.00
Net Cash Flow from Financing Activities-126.00
Effect of exchange rate on cash flow29.00
Discontinued operations0.00
Free Cash Flow58.00
Total Cash Flow-39.00
4 historic quarters locked

Sign in to unlock the full The Chemours cash flow history.

About Chemours Co Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: cc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-065201

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License